Table 3.
Total N=180 |
Mutation | P value | |||||
---|---|---|---|---|---|---|---|
EGFR+ n=35 |
KRAS+ n=63 |
neg/neg n=82 |
KRAS+ vs EGFR+ |
KRAS+ vs neg/neg |
EGFR+ vs neg/neg |
||
Lepidic/bronchioloalveolar | 35 (19) | 15 (43) | 7 (11) | 13 (16) | <0.001 | 0.47 | 0.004 |
Acinar | 106 (59) | 28 (80) | 34 (54) | 44 (54) | 0.016 | 1.00 | 0.008 |
Papillary | 86 (48) | 26 (74) | 22 (35) | 38 (46) | <0.001 | 0.18 | 0.008 |
Micropapillary | 40 (22) | 9 (26) | 12 (19) | 19 (23) | 0.45 | 0.69 | 0.82 |
Complex glandular | 48 (27) | 9 (26) | 21 (33) | 18 (22) | 0.49 | 0.14 | 0.64 |
Solid | 51 (28) | 2 (6) | 28 (44) | 21 (26) | <0.001 | 0.022 | 0.012 |
Mucinous | 17 (9) | 0 | 7 (11) | 10 (12) | 0.048 | 1.00 | 0.032 |
The denominator for shown (percentages) is the total number of cases with each mutation. Pattern was defined as “present” using a ≥20% threshold (see Materials and Methods). neg/neg = cases negative for KRAS and EGFR mutations.